Patent Application
Utility
App. No. 14/799,018
· Confirmation No. 1007
METHODS FOR TREATING BOWEL DISEASES
Applicant:
Salix Pharmaceuticals, Inc.
Abandoned -- Failure to Respond to an Office Action
View Publication ↗
|
⬇ PDF
|
Code | Description | Pages | ||
|---|---|---|---|---|---|
| 2018-09-28 | ABN |
Abandonment | 2 | View | |
| 2018-02-05 | AP.PRE.DEC |
Pre-Brief Appeal Conference decision | 2 | View | |
| 2017-12-07 | AP.PRE.REQ |
Pre-Appeal Brief Conference Request | 2 | View | |
| 2017-12-07 | AP.PRE.REQ |
Pre-Appeal Brief Conference Request | 5 | View | |
| 2017-12-07 | WFEE |
Fee Worksheet (SB06) | 2 | View | |
| 2017-12-07 | N417 |
Electronic Filing System Acknowledgment Receipt | 3 | View | |
| 2017-12-07 | N/AP |
Notice of Appeal Filed | 1 | View | |
| 2017-08-07 | CTFR |
Final Rejection | 10 | View | |
| 2017-08-07 | 1449 |
List of References cited by applicant and considered by examiner | 4 | View | |
| 2017-08-07 | SRFW |
Search information including classification, databases and other search related notes | 1 | View | |
| 2017-08-07 | SRNT |
Examiner's search strategy and results | 1 | View | |
| 2016-12-27 | N570 |
Communication - Re: Power of Attorney (PTOL-308) | 1 | View | |
| 2016-12-21 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2016-12-21 | PA.. |
Power of Attorney | 1 | View | |
| 2016-12-21 | IDS |
Information Disclosure Statement (IDS) Form (SB08) | 4 | View | |
| 2016-12-21 | TRAN.LET |
Transmittal Letter | 2 | View | |
| 2016-12-21 | WFEE |
Fee Worksheet (SB06) | 2 | View | |
| 2016-12-21 | N417 |
Electronic Filing System Acknowledgment Receipt | 3 | View | |
| 2016-12-21 | REM |
Applicant Arguments/Remarks Made in an Amendment | 6 | View | |
| 2016-12-21 | A... |
Amendment/Request for Reconsideration-After Non-Final Rejection | 1 | View | |
| 2016-12-21 | CLM |
Claims | 2 | View | |
| 2016-12-21 | REM |
Applicant Arguments/Remarks Made in an Amendment | 3 | View | |
| 2016-09-22 | CTNF |
Non-Final Rejection | 9 | View | |
| 2016-09-22 | SRFW |
Search information including classification, databases and other search related notes | 1 | View | |
| 2016-09-22 | SRNT |
Examiner's search strategy and results | 1 | View | |
| 2016-08-30 | RCEX |
Request for Continued Examination (RCE) | 3 | View | |
| 2016-08-30 | AMSB |
Amendment Submitted/Entered with Filing of Continued Prosecution Application (CPA)/Request for Continued Examination(RCE) | 1 | View | |
| 2016-08-30 | CLM |
Claims | 1 | View | |
| 2016-08-30 | REM |
Applicant Arguments/Remarks Made in an Amendment | 6 | View | |
| 2016-08-30 | WFEE |
Fee Worksheet (SB06) | 2 | View | |
| 2016-08-30 | N417 |
Electronic Filing System Acknowledgment Receipt | 3 | View | |
| 2016-08-30 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2016-05-31 | CTFR |
Final Rejection | 7 | View | |
| 2016-05-31 | 1449 |
List of References cited by applicant and considered by examiner | 4 | View | |
| 2016-05-31 | SRNT |
Examiner's search strategy and results | 1 | View | |
| 2016-05-31 | SRFW |
Search information including classification, databases and other search related notes | 1 | View | |
| 2016-01-27 | A... |
Amendment/Request for Reconsideration-After Non-Final Rejection | 1 | View | |
| 2016-01-27 | CLM |
Claims | 1 | View | |
| 2016-01-27 | REM |
Applicant Arguments/Remarks Made in an Amendment | 5 | View | |
| 2016-01-27 | IDS |
Information Disclosure Statement (IDS) Form (SB08) | 4 | View | |
| 2016-01-27 | TRAN.LET |
Transmittal Letter | 2 | View | |
| 2016-01-27 | WFEE |
Fee Worksheet (SB06) | 2 | View | |
| 2016-01-27 | N417 |
Electronic Filing System Acknowledgment Receipt | 3 | View | |
| 2016-01-27 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2016-01-07 | NTC.PUB |
Notice of Publication | 1 | View | |
| 2015-11-19 | CTNF |
Non-Final Rejection | 6 | View | |
| 2015-11-19 | 892 |
List of references cited by examiner | 1 | View | |
| 2015-11-19 | BIB |
Bibliographic Data Sheet | 1 | View | |
| 2015-11-19 | 1449 |
List of References cited by applicant and considered by examiner | 7 | View | |
| 2015-11-19 | SRNT |
Examiner's search strategy and results | 1 | View | |
| 2015-11-19 | SRFW |
Search information including classification, databases and other search related notes | 1 | View | |
| 2015-10-07 | PET.OP.DEC |
Office of Petitions Decision (PTO-90) | 2 | View | |
| 2015-10-07 | TRACK1.GRANT |
Track One request Granted | 1 | View | |
| 2015-10-07 | IMIS |
Miscellaneous Internal Document | 1 | View | |
| 2015-10-02 | APP.FILE.REC |
Filing Receipt | 3 | View | |
| 2015-10-02 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2015-09-25 | PEFR |
Applicant Response to Pre-Exam Formalities Notice | 1 | View | |
| 2015-09-25 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2015-09-25 | DRW |
Drawings-only black and white line drawings | 6 | View | |
| 2015-07-29 | APP.FILE.REC |
Filing Receipt | 3 | View | |
| 2015-07-29 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2015-07-29 | NT.CR.APP.PA |
Notice to File Corrected Application Papers | 2 | View | |
| 2015-07-14 | TRNA |
Transmittal of New Application | 1 | View | |
| 2015-07-14 | SPEC |
Specification | 42 | View | |
| 2015-07-14 | CLM |
Claims | 1 | View | |
| 2015-07-14 | ABST |
Abstract | 1 | View | |
| 2015-07-14 | DRW |
Drawings-only black and white line drawings | 6 | View | |
| 2015-07-14 | OATH |
Oath or Declaration filed | 2 | View | |
| 2015-07-14 | LET. |
Miscellaneous Incoming Letter | 2 | View | |
| 2015-07-14 | ADS |
Application Data Sheet | 7 | View | |
| 2015-07-14 | TRAN.LET |
Transmittal Letter | 2 | View | |
| 2015-07-14 | FOR |
Foreign Reference | 3 | View | |
| 2015-07-14 | IDS |
Information Disclosure Statement (IDS) Form (SB08) | 7 | View | |
| 2015-07-14 | WFEE |
Fee Worksheet (SB06) | 2 | View | |
| 2015-07-14 | N417 |
Electronic Filing System Acknowledgment Receipt | 3 | View | |
| 2015-07-14 | TRACK1.REQ |
Track One Request | 1 | View |
Inventors
William Forbes
Raleigh, NC
Lorin K. Johnson
Palo Alto, CA
Attorneys & Agents of Record
Classification
USPC
514/279
A61K31/437
A61P1/00
A61K31/395
A61K31/4184
C12Q1/6883
C12Q2600/156
Prosecution
- Examiner
- LEE, ANDREW P
- Art Unit
- 1621
- Customer No.
- 75093
- Docket No.
- 119557-02305
- Confirmation No.
- 1007
Publication
- Pub. No.
- US20160000765A1
- Pub. Date
- 2016-01-07
Parent
is a Continuation of
→
App. 13/650,188
Filed 2012-10-12
· Abandoned -- Failure to Respond to an Office Action
Parent
is a Continuation of
→
App. 12/393,979
· US 8,309,569
Filed 2009-02-26
· Patented Case
Parent
Claims priority from a provisional application
→
App. 61/102,801
Filed 2008-10-03
· Provisional Application Expired
Parent
Claims priority from a provisional application
→
App. 61/031,679
Filed 2008-02-26
· Provisional Application Expired
ATON PHARMA, INC.,
BAUSCH & LOMB INCORPORATED,
BAUSCH & LOMB PHARMA HOLDINGS CORP.,
COMMONWEALTH LABORATORIES, LLC,
DOW PHARMACEUTICAL SCIENCES, INC.,
ECR PHARMACEUTICALS CO., INC.,
LABORATOIRE CHAUVIN S.A.S.,
MEDICIS PHARMACEUTICAL CORPORATION,
ONPHARMA INC.,
ORAPHARMA, INC.,
PRECISION DERMATOLOGY, INC.,
SALIX PHARMACEUTICALS, LTD.,
SALIX PHARMACEUTICALS, INC.,
SANTARUS, INC.,
SOLTA MEDICAL, INC.,
SYNERGETICS USA, INC.,
TECHNOLAS PERFECT VISION GMBH,
VALEANT CANADA LP,
VALEANT PHARMACEUTICALS INTERNATIONAL,
VALEANT PHARMACEUTICALS INTERNATIONAL, INC.,
VALEANT PHARMACEUTICALS NORTH AMERICA LLC,
WIRRA IP PTY LIMITED,
VALEANT PHARMA POLAND SP. Z O.O.,
VALEANT PHARMACEUTICALS LUXEMBOURG S.A R.L.,
VALEANT PHARMACEUTICALS IRELAND LIMITED
RELEASE OF SECURITY INTEREST
Recorded 2025-11-20
SOLTA MEDICAL, INC.,
PRECISION DERMATOLOGY, INC.,
BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED),
SALIX PHARMACEUTICALS, INC.,
SALIX PHARMACEUTICALS, LTD,
SANTARUS, INC.,
MEDICIS PHARMACEUTICAL CORPORATION,
HUMAX PHARMACEUTICAL S.A.,
SOLTA MEDICAL IRELAND LIMITED,
BAUSCH & LOMB MEXICO, S.A. DE C.V.,
BAUSCH+LOMB OPS B.V.,
BAUSCH HEALTH AMERICAS, INC.,
BAUSCH HEALTH COMPANIES INC.,
BAUSCH HEALTH HOLDCO LIMITED,
BAUSCH HEALTH MAGYARORSZAG KFT (A/K/A BAUSCH HEALTH HUNGARY LLC),
BAUSCH HEALTH POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA (F/K/A VALEANT PHARMA POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA),
BAUSCH HEALTH US, LLC,
BAUSCH HEALTH, CANADA INC. / SANTE BAUSCH, CANADA INC.,
ICN POLFA RZESZOW SPOLKA AKCYJNA (A/K/A ICN POLFA RZESZOW S.A.),
ORAPHARMA, INC.,
PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA SPOLKA AKCYJNA (A/K/A PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA S.A.),
SOLTA MEDICAL DUTCH HOLDINGS B.V.,
V-BAC HOLDING CORP.,
VRX HOLDCO LLC,
1261229 B.C. LTD.,
1530065 B.C. LTD.
RELEASE OF SECURITY INTEREST
Recorded 2025-04-08
from
ATON PHARMA, INC.,
BAUSCH & LOMB INCORPORATED,
BAUSCH & LOMB PHARMA HOLDINGS CORP.,
COMMONWEALTH LABORATORIES, LLC,
DOW PHARMACEUTICAL SCIENCES, INC.,
ECR PHARMACEUTICALS CO., INC.,
LABORATOIRE CHAUVIN S.A.S.,
MEDICIS PHARMACEUTICAL CORPORATION,
ONPHARMA INC.,
ORAPHARMA, INC.,
PRECISION DERMATOLOGY, INC.,
SALIX PHARMACEUTICALS, INC.,
SALIX PHARMACEUTICALS, LTD.,
SANTARUS, INC.,
SOLTA MEDICAL, INC.,
SYNERGETICS USA, INC.,
TECHNOLAS PERFECT VISION GMBH,
VALEANT CANADA LP,
VALEANT PHARMA POLAND SP. Z O.O.,
VALEANT PHARMACEUTICALS INTERNATIONAL,
VALEANT PHARMACEUTICALS INTERNATIONAL, INC.,
VALEANT PHARMACEUTICALS IRELAND LIMITED,
VALEANT PHARMACEUTICALS LUXEMBOURG S.A R.L.,
VALEANT PHARMACEUTICALS NORTH AMERICA LLC,
WIRRA IP PTY LIMITED
SECURITY INTEREST
Recorded 2018-02-26
from
ATON PHARMA, INC.,
BAUSCH & LOMB INCORPORATED,
BAUSCH & LOMB PHARMA HOLDINGS CORP.,
COMMONWEALTH LABORATORIES, LLC,
DOW PHARMACEUTICAL SCIENCES, INC.,
ECR PHARMACEUTICALS CO., INC.,
LABORATOIRE CHAUVIN S.A.S.,
MEDICIS PHARMACEUTICAL CORPORATION,
ONPHARMA INC.,
ORAPHARMA, INC.,
PRECISION DERMATOLOGY, INC.,
SALIX PHARMACEUTICALS, INC.,
SALIX PHARMACEUTICALS, LTD.,
SANTARUS, INC.,
SOLTA MEDICAL, INC.,
SYNERGETICS USA, INC.,
TECHNOLAS PERFECT VISION GMBH,
VALEANT CANADA LP,
VALEANT PHARMA POLAND SP. Z O.O.,
VALEANT PHARMACEUTICALS INTERNATIONAL,
VALEANT PHARMACEUTICALS INTERNATIONAL, INC.,
VALEANT PHARMACEUTICALS IRELAND LIMITED,
VALEANT PHARMACEUTICALS LUXEMBOURG S.A R.L.,
VALEANT PHARMACEUTICALS NORTH AMERICA LLC,
WIRRA IP PTY LIMITED
SECURITY INTEREST
Recorded 2018-02-26
from
ATON PHARMA, INC.,
BAUSCH & LOMB INCORPORATED,
BAUSH & LOMB PHARMA HOLDINGS CORP.,
DENDREON PHARMACEUTICALS, INC.,
DOW PHARMACEUTICAL SCIENCES, INC.,
MEDICIS PHARMACEUTICAL CORPORATION,
OBAGI MEDICAL PRODUCTS, INC.,
OMP, INC.,
ORAPHARMA, INC.,
PRECISION DERMATOLOGY, INC.,
SALIX PHARMACEUTICALS, INC.,
SALIX PHARMACEUTICALS, LTD,
SANTARUS, INC.,
SOLTA MEDICAL, INC.,
VALEANT CANADA LP, BY ITS GENERAL PARTNER VALEANT CANADA GP LIMITED,
VALEANT HOLDINGS IRELAND (AS SUCCESSOR TO VALEANT INTERNATIONAL BERMUDA),
VALEANT PHARMACEUTICALS INTERNATIONAL, INC.,
VALEANT PHARMACEUTICALS IRELAND,
VALEANT PHARMACEUTICALS NORTH AMERICA LLC
SECURITY INTEREST
Recorded 2016-07-18
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded 2015-08-13
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
- App. No.
- 14/799,018
- Filed
- 2015-07-14
- Pub. No.
- US20160000765A1
- Examiner
- LEE, ANDREW P
- Art Unit
- 1621
External Links